Henry Bence Jones and His Protein

Journal of Medical Biography

Volumn 6, Issue 1, 1998, Pages 53-57

  Stone, Marvin J ^a  

^a NONE   (United States)

Author keywords

amyloidosis; Bence Jones; myeloma; proteinuria

Indexed keywords

BENCE JONES PROTEIN;

ART; ARTICLE; HISTORY; HUMAN; MULTIPLE MYELOMA; UNITED KINGDOM;

BENCE JONES PROTEIN; GREAT BRITAIN; HISTORY, 19TH CENTURY; HUMANS; MULTIPLE MYELOMA; PORTRAITS;

EID: 0031993185     PISSN: 09677720     EISSN: 17581087     Source Type: Journal    
DOI: 10.1177/096777209800600112     Document Type: Article

References (53)

1. Rosenbloom J. An appreciation of Henry Bence Jones, MD, FRS (1813–1873). Ann Med Hist 1919;2: 262–4.
2. Coley NG. Henry Bence Jones MD, FRS (1813–1873). Notes Rec R Soc Lond 1973;28: 31–56.
3. Rosenfeld L. Henry Bence Jones (1813–1873): The best “chemical doctor” in London. Clin Chem 1987;33: 1687–92.
4. Putnam FW. Henry Bence Jones: The best chemical doctor in London. Perspect Biol Med 1993;36: 565–79.
5. Jones H Bence. On the presence of sulphur in cystic oxide, and an account of a cystic oxide calculus. Med Chir Soc Trans 1840;23: 192–8.
6. Jones H Bence. On Gravel, Calculus, and Gout: Chiefly an Application of Professor Liebig's Physiology to the Prevention and Cure of these Diseases. London: Taylor and Walton, 1842.
7. Jones H Bence. On intermitting diabetes, and on the diabetes of old age. Med Chir Trans 1853;36: 403–32.
8. Jones H Bence Dupré A. On a fluorescent substance, resembling quinine, in animals; and on the rate of passage of quinine into the vascular and non-vascular textures of the body. Proc R Soc London 1866, 15: 72–93.
9. Obituary. Henry Bence Jones, MD, MA, FRCP, FRS. Med Times Gaz 1873;1: 505–8.
10. Allbutt C. Dr. Bence Jones. In: Coope R, ed. The Quiet Art, A Doctor's Anthology. Edinburgh: E&S Livingstone Ltd, 1958: 74–5.
11. Darwin F. The Life and Letters of Charles Darwin Including an Autobiographical Chapter, vol. 3. London: John Murray, 1887: 31.
12. Huxley L. Life and Letters of Thomas Henry Huxley, vol. 1. New York: Appleton, 1902: 242.
13. Jones H Bence. The Life and Letters of Faraday, vols 1 and 2 (2nd edn). London: Longmans, Green and Co., 1870.
14. Tweney RD. Books and the heroic science of Michael Faraday. AB Bookman, 21 October 1991: 1557–60.
15. Cope Z. Florence Nightingale and the Doctors. London: Museum Press Ltd, 1958: 21–3.
16. Jones H Bence. The Royal Institution: Its Founders and its First Professors. London: Longmans, Green and Co., 1871 (reprinted New York: Arno Press, 1975).
17. Obituary. Dr. Henry Bence Jones. Lancet, 26 April 1873: 614–15.
18. Solly S. Remarks on the pathology of mollifies ossium, with cases. Med Chir Trans 1844;27: 435–61.
19. Kyle RA. History of multiple myeloma. In: Wiernik PH Cancellos GP Dutcher JP Kyle RA, eds. Neoplastic Diseases of the Blood (3rd edn). New York: Churchill Livingstone, 1996: 411–22.
20. Clamp JR. Some aspects of the first recorded case of multiple myeloma. Lancet 1967;ii: 1354–6.
21. Snapper I Kahn A. Historical background. In: Snapper I Kahn A, eds. Myelomatosis. Fundamentals and Clinical Features. Baltimore: University Park Press, 1971: 1–9.
22. MacIntyre W. Case of mollities and fragilitas ossium, accompanied with urine strongly charged with animal matter. Med Chir Soc 1850;33: 211–32.
23. Jones H Bence. Papers on chemical pathology; prefaced by the Gulstonian Lectures, read at the Royal College of Physicians, 1846. Lancet 1847; ii: 88–92.
24. Jones H Bence. On the new substance occurring in the urine of a patient with mollities ossium. Philos Trans R Soc Lond Biol 1848;138: 55–62.
25. Dalrymple J. On the microscopical character of mollities ossium. Dublin J Med Sci 1846;2: 85–95.
26. Roberts W. A Practical Treatise on Urinary and Renal Diseases, Including Urinary Deposits. Philadelphia: Lea Brothers, 1885: 186.
27. von Rustizky J. Multiples myelom. Dtsch Z Chir 1873;3: 162–72.
28. Kahler O. Zur Symptomatologie des multiplen Myeloms; Beobachtung von Albumosurie. Prag Med Wochenschr 1889;14: 45–9.
29. Wright JH. A case of multiple myeloma. Johns Hopkins Hosp Rep 1900;9: 359–66.
30. Osler W. The Principles and Practice of Medicine. New York: D Appleton & Co., 1892: 728.
31. Osler W. The Principles and Practice of Medicine (7th edn). New York: D Appleton & Co., 1909: 674–5.
32. Edelman GM. The structure and function of antibodies. Sci Am 1970;223: 34–42.
33. Geschickter CF Copeland MM. Multiple myeloma. In: Tumors of Bone. New York: American Journal of Cancer, 1931: 430–75.
34. Putnam FW Hardy S. Proteins in multiple myeloma. III. Origin of Bence Jones protein. J Biol Chem 1955;212: 361–9.
35. Korngold L Lipari R. Multiple-myeloma proteins. III. The antigenic relationship of Bence Jones proteins to normal gamma-globulin and multiple-myeloma serum proteins. Cancer 1956;9: 262–72.
36. Porter RR. Structural studies of immunoglobulins. Science 1973;180: 713–16.
37. Edelman GM. Antibody structure and molecular immunology. Science 1973; 180: 830–9.
38. Edelman GM Gaily JA. The nature of Bence Jones proteins. Chemical similarities to polypeptide chains of myeloma globulins and normal ?-globulins. J Exp Med 1962;116: 207–27.
39. Hilschmann N Craig LC. Amino acid sequence studies with Bence Jones proteins. Proc Natl Acad Sci USA 1965;53: 1403–9.
40. Putman FW Titani K Wikler M Shinoda T. Structure and evolution of kappa and lambda light chains. Cold Spring Harb Symp Quant Biol 1967;32: 9–30.
41. Putnam FW. From animal matter to antibody — A trail of research in cancer. Perspect Biol Med 1972;15: 356–79.
42. Putnam FW, ed. Immunoglobulins I. Structure. The Plasma Proteins, vol. 3 (2nd edn). New York: Academic Press, 1977: 1–12.
43. Osserman EF Takatsuki K Talal N. The pathogenesis of “amyloidosis”: Studies on the role of abnormal gamma globulins and gamma globulin fragments of the Bence Jones (1-polypeptide) type in the pathogenesis of “primary” and “secondary amyloidosis”, and the “amyloidosis” associated with plasma cell myeloma. Semin Hematol 1964;1: 3–85.
44. Kyle RA Bayrd ED. “Primary” systemic amyloidosis and myeloma. Discussion of relationship and review of 81 cases. Arch Intern Med 1961;107: 344–53.
45. Glenner GG Terry W Harada M Isersky C Page D. Amyloid fibril proteins. Proof of homology with immunoglobulin light chains by sequence analyses. Science 1971;172: 1150–1.
46. Glenner GG Ein D Eanes ED Bladen HA Terry W Page DL. Creation of ‘amyloid’ fibrils from Bence Jones proteins in vitro. Science 1971;174: 712–14.
47. Stone MJ Frenkel EP. The clinical spectrum of light chain myeloma. A study of 35 patients with special reference to the occurrence of amyloidosis. Am J Med 1975;58: 601–19.
48. Solomon A. Bence Jones proteins and light chains of immunoglobulins. N Engl J Med 1976; 294: 17–23, 91–8.
49. Stone MJ. Amyloidosis: A final common pathway for protein deposition in tissues. Blood 1990;75: 531–45.
50. Buxbaum JN Chuba JV Hellman GC Soloman A Gallo GR. Monoclonal immunoglobulin deposition disease: Light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Ann Intern Med 1990;112: 455–64.
51. Solomon A Weiss DT Katrine AA. Nephrotoxic potential of Bence Jones proteins. N Engl J Med 1991;324: 1845–51.
52. Longo DL. Plasma cell disorders. In: Isselbacher KJ Braunwald E Wilson JD Martin JB Fauci AS Kasper DL, eds. Harrison's Principles of Internal Medicine (13th edn). New York: McGraw-Hill, 1994: 1618–25.
53. Kyle RA. Plasma cell disorders. In: Bennett JC Plum F, eds. Cecil Textbook of Medicine (20th edn). Philadelphia: WB Saunders, 1996: 958–68.